Table 2 |
|||||
|
Associations between predictors and new-onset CKD during a maximum period of 18 years follow-up |
|||||
|
Predictors |
Duration ± SD (months) |
Cases |
Incidence (%) |
Hazard ratio |
95% CI |
|
|
|||||
|
Uric acid (mg/dL) |
|||||
|
> 7.0 |
76.3 ± 63.3 |
32 |
19.3 |
3.99 |
2.59, 6.15 |
|
≤ 7.0 |
98.0 ± 66.8 |
68 |
6.1 |
1.00 |
|
|
HDL-C (mg/dL) |
|||||
|
< 40 |
89.3 ± 61.5 |
18 |
11.8 |
1.69 |
1.00, 2.86 |
|
≥ 40 |
96.0 ± 67.4 |
82 |
7.2 |
1.00 |
|
|
Blood pressure (mmHg) |
|||||
|
SBP ≥ 140 or DBP ≥ 90 |
83.5 ± 62.8 |
33 |
12.9 |
2.00 |
1.29, 3.11 |
|
SBP < 140 and DBP < 90 |
98.1 ± 67.4 |
67 |
6.5 |
1.00 |
|
|
Fasting blood sugar (mg/dL) |
|||||
|
≥ 126 |
95.1 ± 66.0 |
3 |
5.9 |
0.56 |
0.17, 1.77 |
|
< 126 |
95.2 ± 66.8 |
97 |
7.9 |
1.00 |
|
|
Body mass index (kg/m2) |
|||||
|
≥ 25.0 |
93.2 ± 66.4 |
34 |
12.5 |
1.35 |
0.87, 2.10 |
|
< 25.0 |
95.7 ± 66.8 |
66 |
6.5 |
1.00 |
|
|
|
|||||
|
CKD, chronic kidney disease; SD, standard deviation; CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure. |
|||||
|
Kawashima et al. BMC Nephrology 2011 12:31 doi:10.1186/1471-2369-12-31 |
|||||
